Bernardo Goulart

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer
    Bernardo Goulart
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Value Health 14:836-45. 2011

Detail Information

Publications1

  1. ncbi A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer
    Bernardo Goulart
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Value Health 14:836-45. 2011
    ..The cost-utility of adding bevacizumab to chemotherapy in advanced NSCLC remains unknown. We evaluated the cost-utility of bevacizumab added to chemotherapy in patients with advanced NSCLC...